LeMaitre Vascular Inc (LMAT) stock
LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3022% below fair value
$76.10−0.91 (-1.18%)
Close on Nov 17, 2026Market cap $1.74BP/E 26.7Yield 1.05%
LeMaitre Vascular r&d expenses
Research and development expenses are spending on new products and technology.
LeMaitre Vascular's R&D Expenses for the twelve months ending Jun 30, 2026 was $15.41M, up 3.4% year over year. For fiscal 2025 it was $14.14M, down 9.7% from the year before. Over ten years it grew 9.9% a year on average. The highest annual figure on record is $16.97M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.14M | -9.7% |
| FY2024 | Dec 31, 2024 | $15.65M | -7.8% |
| FY2023 | Dec 31, 2023 | $16.97M | +27.6% |
| FY2022 | Dec 31, 2022 | $13.29M | +12.7% |
| FY2021 | Dec 31, 2021 | $11.80M | +16.9% |
| FY2020 | Dec 31, 2020 | $10.10M | +8.9% |
| FY2019 | Dec 31, 2019 | $9.28M | +13.2% |
| FY2018 | Dec 31, 2018 | $8.20M | +23.5% |
| FY2017 | Dec 31, 2017 | $6.64M | +8.1% |
| FY2016 | Dec 31, 2016 | $6.14M | +12.1% |
| FY2015 | Dec 31, 2015 | $5.48M | +17.3% |
| FY2014 | Dec 31, 2014 | $4.67M | -10.9% |
| FY2013 | Dec 31, 2013 | $5.24M | +3.0% |
| FY2012 | Dec 31, 2012 | $5.09M | +15.1% |
| FY2011 | Dec 31, 2011 | $4.43M | -19.4% |
| FY2010 | Dec 31, 2010 | $5.49M | -7.1% |
| FY2009 | Dec 31, 2009 | $5.91M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.85M | +36.9% |
| Q1 FY2026 | Mar 31, 2026 | $4.06M | -0.9% |
| Q4 FY2025 | Dec 31, 2025 | $3.53M | -2.3% |
| Q3 FY2025 | Sep 30, 2025 | $2.97M | -18.8% |
| Q2 FY2025 | Jun 30, 2025 | $3.54M | -17.3% |
| Q1 FY2025 | Mar 31, 2025 | $4.10M | +0.1% |
| Q4 FY2024 | Dec 31, 2024 | $3.62M | -16.8% |
| Q3 FY2024 | Sep 30, 2024 | $3.66M | -13.4% |
| Q2 FY2024 | Jun 30, 2024 | $4.28M | -5.1% |
| Q1 FY2024 | Mar 31, 2024 | $4.09M | +5.6% |
| Q4 FY2023 | Dec 31, 2023 | $4.35M | +22.4% |
| Q3 FY2023 | Sep 30, 2023 | $4.22M | +22.0% |
| Q2 FY2023 | Jun 30, 2023 | $4.52M | +35.0% |
| Q1 FY2023 | Mar 31, 2023 | $3.88M | +32.2% |
| Q4 FY2022 | Dec 31, 2022 | $3.55M | +2.8% |
| Q3 FY2022 | Sep 30, 2022 | $3.46M | +21.6% |
| Q2 FY2022 | Jun 30, 2022 | $3.35M | +26.2% |
| Q1 FY2022 | Mar 31, 2022 | $2.93M | +3.1% |
| Q4 FY2021 | Dec 31, 2021 | $3.46M | +20.5% |
| Q3 FY2021 | Sep 30, 2021 | $2.85M | +35.7% |
| Q2 FY2021 | Jun 30, 2021 | $2.65M | +24.0% |
| Q1 FY2021 | Mar 31, 2021 | $2.84M | -5.0% |
| Q4 FY2020 | Dec 31, 2020 | $2.87M | +14.8% |
| Q3 FY2020 | Sep 30, 2020 | $2.10M | -8.0% |
| Q2 FY2020 | Jun 30, 2020 | $2.14M | -5.2% |
| Q1 FY2020 | Mar 31, 2020 | $2.99M | +33.7% |
| Q4 FY2019 | Dec 31, 2019 | $2.50M | +6.5% |
| Q3 FY2019 | Sep 30, 2019 | $2.28M | +12.0% |
| Q2 FY2019 | Jun 30, 2019 | $2.26M | +13.5% |
| Q1 FY2019 | Mar 31, 2019 | $2.24M | +22.7% |
| Q4 FY2018 | Dec 31, 2018 | $2.35M | +48.3% |
| Q3 FY2018 | Sep 30, 2018 | $2.04M | +15.7% |
| Q2 FY2018 | Jun 30, 2018 | $1.99M | +21.7% |
| Q1 FY2018 | Mar 31, 2018 | $1.83M | +10.1% |
| Q4 FY2017 | Dec 31, 2017 | $1.58M | +4.0% |
| Q3 FY2017 | Sep 30, 2017 | $1.76M | +14.4% |
| Q2 FY2017 | Jun 30, 2017 | $1.63M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.66M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.52M | – |
| Q3 FY2016 | Sep 30, 2016 | $1.54M | – |
See a number that looks wrong?